LTLara Traeger

Lara Traeger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lara Traeger has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a Pilot Randomized Controlled Trial

    by Christina Psaros, Jennifer A Smit, Nzwakie Mosery, Lara N Traeger, Sanelisiwe Mngomezulu, Bongeka Qiya, Busi Maphumulo, Amelia M Stanton, Zoya-Maria R Aoun, C Andres Bedoya, et al.

    Background: South Africa has the largest HIV epidemic in the world; in KwaZulu-Natal Province, over 40.8% of adults aged 15 years and older are living with HIV. Despite this, South Africa is home to only 3% of the world’s health care workers. Nurses constitute the largest group of providers in South Africa and experience high levels of burnout, which can contribute to negative patient outcomes for people living with HIV, including reduced treatment adherence. Nurse-centered interventions that offset these effects are urgently needed. Objective: This study aims to test the feasibility and acceptability of an adapted resiliency intervention (Stress Management and Resiliency Training-Relaxation Response Resiliency Program) for professional nurses who provide care for people living with HIV in South Africa. Methods: In phase 1 (Human Research Ethics Committee [Medical] of the University of the Witwatersrand [220813, Johannesburg, South Africa] and the Massachusetts General Brigham Institutional Review Board [2022P002765, Boston, Massachusetts, United States]), we conducted 3 focus group discussions to solicit feedback on the lived experiences of stress, sources of stress, impact on job functioning, coping strategies, the proposed intervention, and recruitment strategies for nurses. These data informed adaptations to the intervention. In phase 2 (Human Research Ethics Committee [240106, Johannesburg, South Africa]; Massachusetts General Brigham Institutional Review Board [2024P001407, Boston, Massachusetts, United States]), we conducted a small proof-of-concept study (N=8) with preintervention and postintervention assessments, 6 intervention sessions with a nurse interventionist, and a qualitative exit interview. Following appropriate adaptations, we conducted a pilot randomized controlled trial (N=60) in which participants were randomized to the intervention or the control condition. The control condition received a one-time, 90-minute didactic stress management session. The intervention condition consisted of two 4-hour group skills-based sessions on the relaxation response, components of stress, recuperative sleep, mindful awareness, resilience, and social support. Sessions included practice-based exercises and videos to complement the intervention materials. Baseline, posttreatment (intervention only), and follow-up assessments, as well as qualitative exit interviews (n=15, intervention only), were conducted. Primary outcomes are feasibility (number screened, eligible, and enrolled; the number of treatment sessions and assessments completed in the intervention arm; assessment duration; and reasons for declining enrollment and prematurely leaving the trial) and acceptability (Client Satisfaction Questionnaire-8 and qualitative data). Results: The project is funded by the National Institute of Mental Health (R34MH126753; September 2022). As of October 2025, we have completed both the proof-of-concept study (n=8; February 2025) and the pilot randomized controlled trial (n=60; August 2025). Data analysis is in progress and is expected to be completed in August 2026. Conclusions: Structural changes are needed to ensure the well-being of health care providers; however, given that structural changes take time, money, and political capital to execute, we must develop interventions to support providers’ mental health while advocating for systematic change.

  • Multi-modal measurement of shame in relation to perceived stress and avoidance coping in the context of recent HIV diagnosis

    by Abigail W. Batchelder, Tiffany Glynn, Zachary Witkower, Mollie Ruben, Lara Traeger, Hillary S. Schaefer, Hyo Jin (Jenny) Shin, Jessica Tracy, Conall O’CLeirigh, Judith T. Moskowitz

    In stigmatized illnesses such as HIV, shame and other negative self-conscious emotions are associated with sub-optimal engagement in healthcare via stress and avoidance coping. However, shame is challenging to assess via self-report. We employed multimodal measurement to examine whether indicators of shame could predict stress and avoidance coping. Using 319 video-recorded narratives from people recently diagnosed with HIV, we utilized a confirmatory factor analysis on three modalities of shame (self-report, linguistic, and nonverbal postural movement) and connected latent variables to self-reported stress and avoidance coping. Latent self-reported shame was associated with stress and escape-avoidance coping; linguistic shame was associated with stress; postural movements were associated with distancing. Models indicated no second-order factor. Results showed differential associations between measurement modalities of shame, consistent with prior literature on affect measurement, and imply that understanding the connection between shame and healthcare-relevant outcomes necessitates multiple modes of measurement.

  • Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation

    by Areej El-Jawahri, Thomas W. LeBlanc, Ali Kavanaugh, Jason Webb, James Fausto, Lara Traeger, Joseph A. Greer, Vicki Jackson, Nora Horick, Dustin J. Rabideau, et al.

    PURPOSE: Patients undergoing hematopoietic stem cell transplantation (HSCT) and their caregivers endure immense physical and psychological symptoms, which result in quality-of-life (QOL) impairments during HSCT. METHODS: We conducted a multisite randomized trial among adults undergoing autologous or allogeneic HSCT at three academic institutions. Patients were randomly assigned to an inpatient palliative care (PC) intervention or usual care. Intervention patients met with PC clinicians twice weekly during the HSCT hospitalization. Patients assigned to usual care could be referred to PC as per standard of care. We assessed QOL (patient: Functional Assessment of Cancer Therapy-Bone Marrow Transplant; caregiver: Caregiver-Oncology-QOL), depression and anxiety symptoms (Hospital-Anxiety-and-Depression-Scale), and patients' post-traumatic stress disorder (PTSD) symptoms (PTSD Checklist) at baseline, week 2, and 3 and 6 months post-HSCT. The primary end point was patients' QOL at week 2 during hospitalization when patients experience their QOL nadir. We used linear regression, adjusting for baseline scores, to evaluate the effect of the intervention on patient-reported outcomes at week 2. We used linear mixed-effect models to assess the effect of the intervention on study outcomes longitudinally. RESULTS: We enrolled 68.7% (360/524) of eligible patients between October 2018 and July 2022. Compared with those receiving usual care, patients receiving the intervention reported better QOL (adjusted mean difference [B], 6.3; SE, 0.1; P < .001), lower depression (B, –1; SE, 0.4; P = .026), and fewer PTSD symptoms (B, –1.9; SE, 0.9; P = .046) at week 2. Patient-reported anxiety did not differ significantly between groups at week 2. In longitudinal analyses, patients receiving the intervention reported a steeper decline in PTSD symptoms over 6 months post-HSCT (slope difference, –0.9; SE, 0.7; P = .012). All other patient-reported outcomes did not differ longitudinally between the groups. CONCLUSION: PC led to substantial improvements in patients' QOL, depression, and PTSD symptoms with sustained effects on PTSD symptoms up to 6 months post-HSCT.


  • BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation

    by Jamie M. Jacobs, Lara Traeger, Madison Freese, Anna Barata, Richard Newcomb, Dustin Rabideau, Nora Horick, Zachariah DeFilipp, Yi-Bin Chen, Tamryn Gray, et al.

    PURPOSE: Family and friend caregivers of patients undergoing hematopoietic stem-cell transplantation (HSCT) struggle with immense caregiving burden, leading to substantial quality of life (QOL) impairments and psychological distress. Yet, interventions to address caregivers' needs are limited. MATERIALS AND METHODS: We conducted a randomized controlled trial of a psychosocial digital application (BMT-CARE App) versus usual care for adult caregivers of patients with hematologic malignancies undergoing HSCT. The BMT-CARE App included five modules combining psychoeducation and evidence-based behavior change strategies. Participants completed self-report measures at baseline and day 60 post-HSCT. The primary end point was QOL at day 60 assessed by the CareGiver Oncology QOL (CarGOQOL) measure. We also assessed caregiving burden (Caregiver Reaction Assessment), anxiety and depression symptoms (Hospital Anxiety and Depression Scale), and post-traumatic stress disorder (PTSD) symptoms (PTSD Checklist [PCL-5]). We used analysis of covariance adjusting for baseline scores to assess the effect of the intervention on study outcomes. RESULTS: Between February 2023 and July 2024, we enrolled 125 of 174 approached caregivers (71.8%). Participants assigned to the BMT-CARE App used the app for a median of 146.9 minutes (range, 0-384.8). At day 60, BMT-CARE App caregivers reported clinically and significantly better QOL than those assigned to usual care (adjusted means = 76.3 v 69.9, P = .006). BMT-CARE App participants also reported significantly lower caregiving burden (11.2 v 12.3, P = .023), depression (3.8 v 5.6, P = .002), and PTSD symptoms (26.1 v 31.3, P = .012). The groups did not differ significantly in anxiety symptoms at day 60. CONCLUSION: The BMT-CARE App led to significantly improved QOL, caregiving burden, depression, and PTSD symptoms among HSCT caregivers. This intervention should be tested in a multicenter study with a diverse HSCT caregiver population to determine generalizability and scalability.


  • Open Access

    A Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a pilot Randomized Control Trial (Preprint)

    by Christina Psaros, Jennifer A. Smit, Nzwakie Mosery, Lara N. Traeger, Sanelisiwe Mngomezulu, Bongeka Qiya, Busi Maphumulo, Amelia M. Stanton, Zoya-Maria R. Aoun, C. Andres Bedoya, et al.

    UNSTRUCTURED South Africa (SA) has the largest HIV epidemic in the world; in KwaZulu-Natal (KZN) Province, over 40.8% of adults over 15 are living with HIV. Despite this, SA is home to only 3% of the world’s healthcare workers. Nurses constitute the largest group of providers in SA and experience high levels of burnout, which can contribute to negative patient outcomes for persons living with HIV (PWH), including reduced treatment adherence. Patient-provider relationships are the gateway to engagement and retention in HIV care yet relationships can be compromised in overburdened nurses. Nurse-centered interventions that offset these effects are urgently needed. The purpose of this study is to pilot an adapted resiliency-based mind-body intervention (the Relaxation Response Resiliency Program; the 3RP) for nurses that provide care for PWH in the public sector in SA. In Phase 1 [NIH Grant Number: R34MH131426; HREC Ethics Reference Number: 220813], we conducted focus group discussions to solicit feedback on: the role of culture and perceptions of stress; the lived experiences of stress; sources of stress (e.g., occupational, trauma-related); how stress impacts job functioning (specifically patient care); current coping strategies; and the proposed intervention modules (content, number of sessions, session duration, program length, use of coaches, mode of delivery (e.g., virtual, in-person, hybrid approaches), etc.). In this Phase 2, we will conduct a small proof-of-concept study (N = 8-10), followed by a randomized pilot (N = 60), of nurses that care for PWH in the public sector in SA to test the feasibility and acceptability of the adapted intervention.

  • Top Cited Papers

    Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study

    by Mary C. Boulanger, Ayo S. Falade, Kelly Hsu, Robert K. Sommer, Ashley Zhou, Roshni Sarathy, Donald Lawrence, Ryan J. Sullivan, Lara Traeger, Joseph A. Greer, et al.

    PURPOSE: Immunotherapy has improved survival for patients with melanoma and non–small cell lung cancer (NSCLC). Yet, as responses vary widely, immunotherapy also introduces challenges in prognostic communication. In this study, we sought to explore how patients and caregivers learned about the goal of immunotherapy and their experience of living with uncertainty. MATERIALS AND METHODS: We conducted a qualitative study of patients with stage III or IV melanoma or stage IV NSCLC within 12 weeks of initiating or 12 months of discontinuing immunotherapy, and their caregivers. We conducted in-depth interviews with participants to explore how they learned about immunotherapy from oncology clinicians and how they experienced uncertainty. We used a framework approach to analyze interview transcripts and synthesized concepts into themes. RESULTS: Forty-two patients and 10 caregivers participated; median age was 67 years and most were male (68%), white (95%), married (61%), and had melanoma (62%). We identified four themes: (1) the oncology team shaped participants' hopeful expectations of immunotherapy, including as a potential cure among those with melanoma; (2) distress related to prognostic uncertainty particularly affected patients who experienced toxicity or progressive disease; (3) patients who did not have long-term responses experienced overwhelming disappointment; and (4) some patients and caregivers had conflicting preferences for prognostic information. Participants provided suggestions to improve education and underscored unmet psychosocial needs. CONCLUSION: Patients and caregivers held optimistic expectations of immunotherapy, which resulted in heightened disappointment among the subset with progression or toxicity. Clinicians should elicit information preferences of both patients and caregivers, as these may be disparate. Our results highlight the need to optimize prognostic communication and support for living with uncertainty among patients receiving immunotherapy.


  • Yin and Yang of Psychological Health in the Cancer Experience: Does Positive Psychology Have a Role?

    by Hermioni L. Amonoo, Areej El-Jawahri, Emma C. Deary, Lara N. Traeger, Corey S. Cutler, Joseph A. Antin, Jeff C. Huffman, Stephanie J. Lee

    Positive psychological wellbeing in patients with cancer has received limited clinical attention to date #timetochangetheparadigm#positivepsych


  • Communicating the Information Needed for Treatment Decision Making Among Patients With Pancreatic Cancer Receiving Preoperative Therapy

    by Howard J. Lee, Carolyn L. Qian, Sophia L. Landay, Deirdre O'CAllaghan, Emilia Kaslow-Zieve, Chinenye C. Azoba, Charn-Xin Fuh, Brandon Temel, Nneka Ufere, Laura A. Petrillo, et al.

    PURPOSE: Preoperative therapy for pancreatic cancer represents a new treatment option with the potential to improve outcomes for patients, yet with complex risks. By not discussing the potential risks and benefits of new treatment options, clinicians may hinder patients from making informed decisions. METHODS: From 2017 to 2019, we conducted a mixed-methods study. First, we elicited clinicians' (n = 13 medical, radiation, and surgery clinicians), patients' (n = 18), and caregivers' (n = 14) perceptions of information needed for decision making regarding preoperative therapy and generated a list of key elements. Next, we audio-recorded patients' (n = 20) initial multidisciplinary oncology visits and used qualitative content analyses to describe how clinicians discussed this information and surveyed patients to ask if they heard each key element. RESULTS: We identified 13 key elements of information patients need when making decisions regarding preoperative therapy, including treatment complications, alternatives, logistics, and potential outcomes. Patients reported hearing infrequently about complications (eg, hospitalizations [n = 3 of 20]) and alternatives (n = 8 of 20) but frequently recalled logistics and potential outcomes (eg, likelihood of surgery [n = 19 of 20]). Clinicians infrequently discussed complications (eg, hospitalizations [n = 7 of 20]), but frequently discussed alternatives, logistics, and potential outcomes (eg, likelihood of surgery [n = 20 of 20]). No overarching differences in clinician discussion content emerged to explain why patients did or did not hear about each key element. CONCLUSION: We identified key elements of information patients with pancreatic cancer need when considering preoperative therapy. Patients infrequently heard about treatment complications and alternatives, while frequently hearing about logistics and potential outcomes, underscoring areas for improvement in educating patients about new treatment options in oncology.